Plasma Proteome-Driven Liquid Biopsy for Individualized Monitoring and Risk Stratification of Immune-Related Adverse Events in Checkpoint Immunotherapy
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Dongxue Yan
raw_affiliation_strings: Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China; School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, China
School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, 325027, China; Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150001, P. R. China
raw_author_name: Jingjing Xu
raw_affiliation_strings: Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, P. R. China
Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, 150081, P. R. China
raw_author_name: Dawei Wang
raw_affiliation_strings: Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, P. R. China
Department of Intensive Care Medicine, Tianjin Medical University Cancer Hospital, Tianjin, P. R. China
Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150001, P. R. China; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, 150081, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, 150000, P. R. China
raw_author_name: Qian Xing
raw_affiliation_strings: Department of ICU, Fudan University Shanghai Cancer Center, Shanghai, P. R. China; Department of Anathesia, Critical Care and Pain, Fudan University Shanghai Cancer Center, Shanghai, P. R. China
Department of ICU, Fudan University Shanghai Cancer Center, No270 Dongan Road, Shanghai, 200032, P. R. China; Department of Anathesia, Critical care and pain, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China
raw_author_name: Xinrong He
raw_affiliation_strings: Department of Intensive Care Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China
Department of Intensive Care Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
raw_author_name: Donghao Wang
raw_affiliation_strings: Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, P. R. China
Department of Intensive Care Medicine, Tianjin Medical University Cancer Hospital, Tianjin, P. R. China
Department of Intensive Care Medicine, Tianjin medical university cancer hospital, Tianjin 300060, P. R. China
raw_author_name: Biao zhu
raw_affiliation_strings: Department of ICU, Fudan University Shanghai Cancer Center, Shanghai, P. R. China; Department of Anathesia, Critical Care and Pain, Fudan University Shanghai Cancer Center, Shanghai, P. R. China
Department of ICU, Fudan University Shanghai Cancer Center, No270 Dongan Road, Shanghai, 200032, P. R. China; Department of Anathesia, Critical care and pain, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China
raw_author_name: Kaijiang Yu
raw_affiliation_strings: Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, P. R. China. Electronic address: DrKaijiang@163.com
Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150001, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, 150000, P. R. China. Electronic address: DrKaijiang@163.com
raw_author_name: Meng Zhou
raw_affiliation_strings: School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, China. Electronic address: zhoumeng@wmu.edu.cn
School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, 325027, China. Electronic address: zhoumeng@wmu.edu.cn
raw_author_name: Changsong Wang
raw_affiliation_strings: Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P. R. China; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, P. R. China. Electronic address: changsongwangicu@163.com
Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150001, P. R. China; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, 150081, P. R. China; Heilongjiang Provincial Key Laboratory of Critical Care Medicine, Harbin Medical University, Harbin, 150000, P. R. China. Electronic address: changsongwangicu@163.com